Sanofi Pasteur
2Patents
2Active
2Granted
42Portfolio score
Filing activity: Nov 18, 2004 → Oct 25, 2011 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9169298B2 | Dengue serotype 1 attenuated strain | Emerging Cross-Sectional Technologies | 3 | Active |
| US8299210B2 | Methods for purifying pertussis toxin and peptides useful therefor | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.